Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Cumulative evidence indicates that mitochondrial dysfunction has a role in heart failure progression, but whether mitochondrial quality control mechanisms are involved in the development of cardiac dysfunction remains unclear. Here we show that cytosolic p53 impairs autophagic degradation of damaged mitochondria and facilitates mitochondrial dysfunction and heart failure in mice. Prevalence and induction of mitochondrial autophagy is attenuated by senescence or doxorubicin treatment in vitro and in vivo. We show that cytosolic p53 binds to Parkin and disturbs its translocation to damaged mitochondria and their subsequent clearance by mitophagy. p53-deficient mice show less decline of mitochondrial integrity and cardiac functional reserve with increasing age or after treatment with doxorubicin. Furthermore, overexpression of Parkin ameliorates the functional decline in aged hearts, and is accompanied by decreased senescence-associated β-galactosidase activity and proinflammatory phenotypes. Thus, p53-mediated inhibition of mitophagy modulates cardiac dysfunction, raising the possibility that therapeutic activation of mitophagy by inhibiting cytosolic p53 may ameliorate heart failure and symptoms of cardiac ageing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Defective mitophagy has also been linked with premature aging and many age-associated disorders, such as Alzheimer’s and Parkinson’s diseases (25–28).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [27]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A recent study has shown that increased p53 cytosolic localization prevents Parkin translocation to mitochondria during organismal aging (27).”
From Impaired mitophagy leads to cigarette smoke stress‐induced cellular senescence: implications for chronic obstructive pulmonary disease (2015) · cites this paper as [27]
Experimental — accuracy not yet measuredIn the citing paper
“| Cardiomyopathies | Whole‐body deletion of Tp53 | Decelerated cardiac aging, linked to improved mitophagic responses after stabilization of PRKN | Hoshino et al (2013) |”
From Autophagy in major human diseases (2021) · cites this paper as Hoshino et al (2013)
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Parkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026
Youle, R. J., & Narendra, D. P. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3028 · Cited by 3,273
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
The Failing Heart — An Engine Out of Fuel
Neubauer, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra063052 · Cited by 2,417
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,272
Cited by
Items 401–500 of 533
Kang, D., Baek, Y., & Lee, J. (2022) · Cells · doi:10.3390/cells11244062 · Cited by 10
“Cardiomyocyte-specific overexpression of Parkin improves cardiac function and reduces the positivity of senescence-associated β-galactosidase (SA-β-Gal) through increasing Parkin-mediated mitophagy in aged mice [173].”
BackgroundMitophagy disorder mediates cardiac deterioration induced by severe hypoglycemia in diabetic mice
Huang, C., Huang, L., Huang, Q., Lin, L., Wang, L., Wu, Y., Wu, K., Gao, R., Liu, X., Liu, X., et al. (2023) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2023.111994 · Cited by 9
Guo, X., Chen, Z., Liu, Y., Chen, Z., Lin, M., Zhang, L., Zhu, P., Yang, J., Wang, Z., Zhang, J., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155911 · Cited by 10
Borlak, J. T., Ciribilli, Y., Bisio, A., Selvaraj, S., Inga, A., Oh, J., & Spanel, R. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05623-8 · Cited by 9
“Prkn/parkin inhibits the mitophagy-promoting function of p53 in mouse heart [105], and its repression supports survival.”
BackgroundCell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson’s Disease
Patel, J., Panicker, N., Dawson, V. L., & Dawson, T. M. (2022) · CNS Drugs · doi:10.1007/s40263-022-00973-7 · Cited by 9
Apoptosis and long non-coding RNAs: Focus on their roles in Heart diseases
Al‐Masri, A. A. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154889 · Cited by 9
Guan, Y., Zhang, M., Lacy, C., Shah, S. A., Epstein, F. H., & Yan, Z. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25010633 · Cited by 10
Yin, Y., Huang, M., Xie, J., Ou, Y., & Mai, T. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102382 · Cited by 10
“Empowering” Cardiac Cells via Stem Cell Derived Mitochondrial Transplantation- Does Age Matter?
Mietsch, M., & Hinkel, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041824 · Cited by 9
“Mitophagy rates decrease during aging [75,76] and there are alterations in the mitochondrial integrity [77].”
BackgroundMuscle-specific programmed cell death 5 deletion attenuates cardiac aging
Naz, A., Zhang, S., An, L. K., Song, Z., Zi, Z., Wu, J., Lai, S., Mazhar, H., Xu, M., Chen, Y., et al. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.10.142 · Cited by 10
Mitochondrial DNA Mutations and Ageing
Whitehall, J. C., Smith, A. L. M., & Greaves, L. C. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_4 · Cited by 10
Mitochondrial homeostasis: a potential target for delaying renal aging
Yang, M., Liu, C., Jiang, N., Liu, Y., Luo, S., Li, C., Zhao, H., Han, Y., Chen, W., Li, L., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1191517 · Cited by 11
“Studies have shown that the levels of mitophagy in the dentate gyrus, heart, and skeletal muscle were significantly reduced in older mice compared to controls (Hoshino et al., 2013; Sun et al., 2015; Garcia-Prat et al., 2016), and similar results were observed in the heart and skeletal muscle of older humans (Martinez…”
ResultXie, F.-M., Zeng, K., Chen, Z., Li, G., Lin, Z.-F., Zhu, X., & Sun, L. (2007) · PubMed · Cited by 11
Role of mitophagy in spinal cord ischemia-reperfusion injury
Duan, Y., Yang, F., Zhang, Y., Zhang, M., Shi, Y., Lang, Y., Sun, H., Wang, X., Jin, H., & Kang, X. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00668 · Cited by 8
“Pifithrin-α, a specific inhibitor of p53, improves mitophagy (Hoshino et al., 2013).”
Huang, B., & Hu, X. (2025) · Aging and Disease · doi:10.14336/ad.2025.0541 · Cited by 10
“P53 inhibits Parkin-mediated mitochondrial autophagy and promotes mitochondrial dysfunction in the mouse heart [118].”
Arnhold, J. (2025) · Biomolecules · doi:10.3390/biom15040547 · Cited by 8
Mitochondrial Membrane Intracellular Communication in Healthy and Diseased Myocardium
Kumar, V. K., Lackey, A. I., Snyder, J. E., Karhadkar, S. S., Rao, A. D., DiCarlo, A., & Sato, P. Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.609241 · Cited by 8
“…and Developmental Biology | www.frontiersin.org 8 December 2020 | Volume 8 | Article 609241 dysfunction, suggesting that activation of mitophagy could be a potential target for therapy in diseases related to aging or mitochondrial dysfunction (Hoshino et al., 2013; Pires Da Silva et al., 2020).”
BackgroundWang, R., Xu, Y., Niu, X., Fang, Y., Guo, D. S., Chen, J., Zhu, H., Dong, J., Zhao, R., Wang, Y., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.646903 · Cited by 8
RetractedYang, Z., Sun, L., & Wang, H. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1166324 · Cited by 8
“Mitophagy is known to increase during cardiac stress and injury, helping to clear damaged mitochondria and prevent oxidative damage as well as cell death (27, 28).”
BackgroundMitochondrial Reactive Oxygen Species in Cellular Senescence
Nacarelli, T., Torres, C. A., & Sell, C. (2016) · Healthy ageing and longevity · doi:10.1007/978-3-319-26239-0_10 · Cited by 11
Iwasawa, T., Shinomiya, T., Ota, N., Shibata, N., Nakata, K., Shiina, I., & Nagahara, Y. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00643 · Cited by 8
Hu, S., Yang, M., Liu, T., Huang, M., Ju, H., Liu, Z., Kashkooli, S., Cheng, M., & Wu, G. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104045 · Cited by 10
“…of ROS in mitochondria after DOX-treatment can inhibit the activity of electron transfer chain (ETC) complexes I, II, and IV proteins, thereby interrupting the production of mitochondrial energy, disrupting the mitochondrial respiratory chain and membrane potential, and reducing ATP generation [6].”
Mitochondrial quality control in health and disease: mechanisms and therapeutic targets
Creus, A., Mohapatra, S., Ortega, L., & Sebastián, D. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02813-2 · Cited by 13
“222 One possible explanation for this decline in mitophagy is increased Shank3 levels in aging hearts.”
Евгеньевна, К. К., Wegner, E. A., & Барбараш, О. Л. (2022) · Kardiologiia · doi:10.18087/cardio.2022.3.n1206 · Cited by 9
Monitoring Mitochondrial Morphology and Respiration in Doxorubicin-Induced Cardiomyopathy
Abdullah, C. S., Aishwarya, R., Morshed, M., Remex, N. S., Miriyala, S., Panchatcharam, M., & Bhuiyan, M. S. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2309-1_13 · Cited by 7
Ping, Z., Zhang, S., Du, X., Kehe, H., Chen, X., & Chunfeng, W. (2024) · Food and Chemical Toxicology · doi:10.1016/j.fct.2024.114714 · Cited by 10
The role of autophagy in the progression of HIV infected cardiomyopathy
Sun, Y., Xu, M., Duan, Q., Bryant, J., & Xu, X. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1372573 · Cited by 8
Autophagy in benign prostatic hyperplasia: insights and therapeutic potential
Zhou, X.-Z., Huang, P., Wu, Y.-K., Yu, J.-B., & Sun, J. (2024) · BMC Urology · doi:10.1186/s12894-024-01585-7 · Cited by 9
“Dysfunction in mitochondrial autophagy has been observed in the hearts [44], skeletal muscles [45], and brains [46] of aged mice.”
BackgroundYousef, A., Fang, L., Heidari, M., Kranrod, J. W., & Seubert, J. M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1486717 · Cited by 10
Rejuvenation of the Aging Heart: Molecular Determinants and Applications
Alibhai, F. J., & Li, R. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.03.004 · Cited by 9
Metformin and myocardial ischemia and reperfusion injury: Moving toward “prime time” human use?
Chen, Q., & Lesnefsky, E. J. (2020) · Translational research · doi:10.1016/j.trsl.2020.10.006 · Cited by 7
Mitochondrial Dysfunction in Aging, HIV, and Long COVID: Mechanisms and Therapeutic Opportunities
Delpino, M. V., & Quarleri, J. F. (2025) · Pathogens · doi:10.3390/pathogens14101045 · Cited by 8
Fueling the fire: metabolic dysfunction and senescence as drivers of lung aging and disease
Kliment, C. R., Gurkar, A. U., Cárdenes, N., Ramonell, R. P., Finkel, T., & Königshoff, M. (2026) · Physiological Reviews · doi:10.1152/physrev.00024.2025 · Cited by 7
Wu, Z., Liang, J., Huang, W. C., Jiang, L., Paul, C., Lin, B., Zheng, J., & Wang, Y. (2021) · Cells · doi:10.3390/cells10112912 · Cited by 6
Implications of p53 in mitochondrial dysfunction and Parkinson’s disease
Wang, Y., Wang, Y.-D., Gao, S., & Sun, W. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2158824 · Cited by 8
“Moreover, p53 directly inactivates the translocation of Parkin from the cytosol to damaged mitochondria through its interaction with Parkin, leading to the formation of toxic aggregates and mitochondrial dysfunction [ 153 ].”
Effect of Spermidine on Endothelial Function in Systemic Lupus Erythematosus Mice
Kim, H., & Massett, M. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189920 · Cited by 8
“The importance of recruiting parkin and parkin-mediated mitophagy was demonstrated in studies that showed accumulated mtDNA mutations and oxidative stress along with a reduced life span in parkin null mice [15,16].”
BackgroundTMBIM1 ameliorates sepsis‐induced cardiac dysfunction by promoting Parkin‐mediated mitophagy
Huang, W., Lou, A., Wang, J., Wang, Y., Zhang, W., Li, J., Wang, S., Geng, S., Wang, G., & Li, X. (2025) · The FASEB Journal · doi:10.1096/fj.202402599rr · Cited by 7
“34 We compared mitochondrial morphology in heart tissues from Ad-TMBIM1, Ad-GFP, Adsh-TMBIM1, Adsh-SCR, and WT rats at baseline and after LPS challenge by TEM.”
Guan, X., Li, W., Wang, Y., Zhao, Q., Yu, X., Jiang, J., Bian, W., Xu, C., Sun, Y., & Zhang, C. (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.01.012 · Cited by 6
Doxorubicin-Induced Cardiotoxicity
Zhu, H. (2018) · InTech eBooks · doi:10.5772/intechopen.78791 · Cited by 7
“In addition, DOX enhances p53 expression, which promotes its interaction with Parkin and prevents Parkin translocation from cytoplasm to mitochondria [35].”
BackgroundPathological Relationship between Intracellular Superoxide Metabolism and p53 Signaling in Mice
Watanabe, K., Shibuya, S., Ozawa, Y., Toda, T., & Shimizu, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073548 · Cited by 7
“Since suppression of p53 via pharmacological as well as genetic approaches ameliorated heart failure [29,33,34], p53 is considered a key molecule involved in heart failure.”
BackgroundImpact of Aging and Cellular Senescence in the Pathophysiology of Preeclampsia
Suvakov, S. R., Kattah, A. G., Gojković, T., Enninga, E. A. L., Pruett, J. E., Jayachandran, M., Sousa, C., Santos, J., Hassan, C. A., Suarez, M. L. G., et al. (2023) · Comprehensive physiology · doi:10.1002/cphy.c230003 · Cited by 6
Vieira, J., Barros, M., López-Fernández, H., Glez‐Peña, D., Nogueira-Rodríguez, A., & Vieira, C. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031325 · Cited by 6
The drug discovery and therapeutic nano-strategies targeting cellular senescence
Wang, Y., Liu, M., Chen, X., Wang, S., Li, J., Sun, Y., Zheng, X., Zhang, J.-X., & Li, H. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102480 · Cited by 13
Seo, J., Park, S., Lee, D. C., Yoo, W., Yang, Y. R., Seo, H. W., Park, J. L., Joo, J., Park, K. C., & Byun, S. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02688-3 · Cited by 9
Qi, B., Li, T., Luo, H., Hu, L., Feng, R., Wang, D., Peng, T., Ren, G., Guo, D. S., Liu, M., et al. (2024) · MedComm · doi:10.1002/mco2.503 · Cited by 5
“30 These two studies aroused our attention. p53 can promote mitochondrial dysfunction by inhibiting Parkin-mediated mitophagy, 31,32 and GRP78, a key ER stress protein, plays an essential role in MI pathogenesis.”
The Role of Mitochondrial Dynamics in Doxorubicin‐Induced Disease: Implications for Therapy
Yue, H., CHEN, Y.-S., Feng, J., Yue, W., & Shi, X. (2025) · Journal of Cellular Physiology · doi:10.1002/jcp.70064 · Cited by 5
Autophagy in striated muscle diseases
Bailin, P. L., Zhang, L., Zhang, L., & Han, R. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1000067 · Cited by 7
“In addition to the core components, the maintenance of heart fitness also requires the involvement of some other regulatory proteins of PINK1/PRAK2-mediated mitophagy such as TAM41 Mitochondrial Translocator Assembly and Maintenance Homolog (TAMM41) (63), acetyl-CoA carboxylase 2 (ACC2) (64), tumor protein p53 (p53) (…”
BackgroundAndreev, D. A., Balakin, E. I., Самойлов, А. С., & Pustovoit, V. I. (2024) · Drug development & registration · doi:10.33380/2305-2066-2024-13-1-1508 · Cited by 6
Feng, Z., Yuan, L., Ma, L., Yu, W., Kheir, F. M., Käsmann, L., Brueckl, W. M., Jin, K., Wang, D., Shen, Y., et al. (2024) · Translational Lung Cancer Research · doi:10.21037/tlcr-24-344 · Cited by 7
Molecular Mechanisms Underlying Anthracycline Cardiotoxicity: Challenges in Cardio-Oncology
Dhingra, R., Margulets, V., & Kirshenbaum, L. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803547-4.00002-1 · Cited by 8
Localization of Injury and Repair Pathways
Angelotti, M. L., Lazzeri, E., & Romagnani, P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00032-7 · Cited by 6
Mitophagy Facilitates Cytosolic Proteostasis to Preserve Cardiac Function
Rawnsley, D. R., Islam, M., Zhao, C., Guan, X., Kooh, Y. K. G., Mendoza, A. D., Navid, H., Kumari, M., Pandi, P., Murphy, J. T., et al. (2026) · Circulation Research · doi:10.1161/circresaha.126.328328 · Cited by 5
Deficit of Female Sex Hormones Desensitizes Rat Cardiac Mitophagy
Kampaengsri, T., Ponpuak, M., Wattanapermpool, J., & Bupha‐Intr, T. (2021) · The Chinese Journal of Physiology · doi:10.4103/cjp.cjp_102_20 · Cited by 4
The MAD2B‐APC / C‐MDM2 axis mediates acute kidney injury by modulating p53
Hao, Z., Yuan, Q., Tang, H. R., Lei, C., Chen, Y., Su, H., & Zhang, C. (2023) · FEBS Journal · doi:10.1111/febs.16786 · Cited by 4
Eşrefoğlu, M. (2022) · International Journal of Pharmaceutical and Bio-Medical Science · doi:10.47191/ijpbms/v2-i6-07 · Cited by 4
Zhuang, J., Zhu, J. H., Dou, Y., Chen, X., Chen, H., Liu, X., Lin, G., & Ruan, F. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-5350 · Cited by 4
“In addition, P53 protein also destroys the ability of myocardial damaged mitochondria to degrade autophagy, leading to myocardial mitochondrial dysfunction and promoting the development of HF (27).”
BackgroundAzam, T., Zhang, H., Zhou, F., & Wang, X. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.888190 · Cited by 4
“Parkin overexpression were found to ameliorate heart failure symptoms (Hoshino et al., 2013).”
BackgroundLate-onset Mitochondrial Cardiomyopathy Triggered by Anticancer Treatment
Yamasaki, T., Yanishi, K., Tateishi, S., Nakanishi, N., Zen, K., Nakamura, T., Yamano, T., Shiraishi, H., Shirayama, T., & Matoba, S. (2017) · Internal Medicine · doi:10.2169/internalmedicine.56.8076 · Cited by 4
“Abnormal mitochondrial proliferation and the suppression of mitochondrial decomposition can be confirmed by electron microscopy (10).”
BackgroundSelf-citationAdvances and challenges in modeling Charcot-Marie-Tooth type 2A using iPSC-derived models
Rizzuti, M., Pagliari, E., D’Agostino, M., Ottoboni, L., Parente, V., Comi, G. P., Corti, S. P., Rizzo, F., & Abati, E. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102711 · Cited by 3
Interconnected Pathways and Therapeutic Implications for Cardiovascular Aging and Diseases
Bai, X., Zhang, Y., Qu, J. T., & Liu, G. (2025) · JACC Asia · doi:10.1016/j.jacasi.2025.10.017 · Cited by 3
Ashiba, K., Mino, K., Okido, Y., Sato, K., & Kawakami, H. (2022) · Journal of Artificial Organs · doi:10.1007/s10047-022-01356-x · Cited by 4
Autophagie et système cardiovasculaire
Kheloufi, M., Rautou, P., & Boulanger, C. M. (2017) · médecine/sciences · doi:10.1051/medsci/20173303015 · Cited by 5
“La surexpression de Parkin, ainsi que la déficience en p53, préviennent la sénescence cellulaire et le déclin de la fonction cardiaque au cours du vieillissement [7, 8].”
BackgroundSpaulding, H. R., Ballmann, C. G., Quindry, J. C., Hudson, M., & Selsby, J. T. (2019) · JRSM Cardiovascular Disease · doi:10.1177/2048004019879581 · Cited by 3
Mastering cardiomyocyte mitophagy: molecular governance, pathological derailment and therapeutics
Liu, P., Wu, H., Ren, H., Wang, J., & Yang, F. (2026) · PeerJ · doi:10.7717/peerj.20700 · Cited by 5
“Extensive studies in cardiomyocytes show that mitophagy driven by the PINK1 and Parkin pathway is elicited by mitochondrial dysfunction and by diverse pathological stresses ( Hoshino et al., 2013 ; McWilliams et al., 2018 ).”
Xu, H., Lin, D., Dai, X., Zhang, J., Shi, J., Lu, Q., & Gu, Z. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01427-2 · Cited by 2
Two Routes for Removing Unhealthy Mitochondria: Degradation and Secretion
Fang, X., & Gustafsson, Å. B. (2026) · Circulation Research · doi:10.1161/circresaha.125.326985 · Cited by 2
Jiang, M., Wang, T., Xin, G., Zhou, Q., Zhang, Y., Shi, J., Hu, J., Wu, J., Liu, T., Xu, X., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158228 · Cited by 2
The director of cell fate: p53 plays roles in programmed cell death
Gan, Y., & Zhou, X. (2025) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2025-0007 · Cited by 4
Mechanism and Regulation of Selective Mitophagy in Cardiometabolic Disease
Yang, Z., Lv, J., Ren, J. T., & Sun, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-805253-2.00004-3 · Cited by 3
Mitochondrial dyshomeostasis in cardiac aging and related diseases
Wang, J., YuJing, L. I., ZHANG, H., SiQi, C. H. E. N., Wang, Y., & Song, M. (2023) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0366 · Cited by 4
Autophagy Induction: A Promising Antiaging Strategy
Singh, A. K., Singh, S., & Rizvi, S. I. (2018) · Springer eBooks · doi:10.1007/978-981-13-1699-9_11 · Cited by 2
Editorial commentary: Mitochondrial autophagy in cardiac aging is all fluxed up
Kubli, D. A., & Sussman, M. A. (2017) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2017.12.008 · Cited by 2
“The deleterious effects of Parkin deficiency only surface after severe injury, such as acute myocardial infarction [4].”
InfluentialUbiquitin E3 Ligases and p53 in Doxorubicin-Induced Cardiotoxicity
Tachibana, S., Otaki, Y., Goto, J., Watanabe, T., & Watanabe, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110252 · Cited by 2
“Previous reports have shown that activated cytosolic p53 binds to Parkin and disrupts its translocation to damaged mitochondria and subsequent clearance by mitophagy in DIC [163].”
Han, J., Li, X., Dong, Y., Wang, Y., Lv, S., Zhang, Y., Zhao, R., Yan, Y., Han, Y., Wang, Y., et al. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025223 · Cited by 1
“Parkin, a critical mediator of mitochondrial quality control, has been implicated in determining cell fate upon mitochondrial damage [34–36].”
Cellular Senescence in Heart Failure: A Review
Krauz, K., Czarzasta, K., Bugajewski, M., Momot, K., Wojciechowska, M., & Cudnoch‐Jędrzejewska, A. (2026) · Journal of Cellular Physiology · doi:10.1002/jcp.70136 · Cited by 2
“Therefore, cytosolic accumulation of p53 prevents mitophagy by inhibition of parkin which leads to mitochondrial dysfunction (Hoshino et al. 2013; Manzella et al. 2018).”
Qian, Y., Lu, Y., Chang, M., Niu, Q., Fan, J., Xing, S., Li, P., & Liu, L. (2026) · Phytotherapy Research · doi:10.1002/ptr.70241 · Cited by 1
“In the present study, we induced a senile model using low-dose doxorubicin (DOX) (Hoshino et al. 2013; Spallarossa et al. 2010).”
InfluentialYang, X., Cheng, K., Chen, C., Zhang, Y., & Wang, D. W. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177734 · Cited by 1
“Cytosolic p53 also suppresses Parkin-mediated mitophagy and promotes mitochondrial dysfunction [75].”
Generation of inducible mitophagy mice
Nishiji, T., Hoshino, A., Uchio, Y., & Matoba, S. (2023) · Genes to Cells · doi:10.1111/gtc.13091 · Cited by 1
“The tumor suppressor p53 also prevents mitophagy by blocking Parkin translocation to mitochondria, and inhibition of p53 activates mitophagy and is effective in attenuating heart failure (Hoshino et al., 2013).”
BackgroundInfluentialSelf-citationSuppressing the Aging Phenotype of Mesenchymal Stromal Cells: Are We Ready for Clinical Translation?
Roato, I., Visca, M., & Mussano, F. D. (2024) · Biomedicines · doi:10.3390/biomedicines12122811 · Cited by 1
Mitochondria as Signaling Platforms
Yoboue, E. D., Manon, S., & Camougrand, N. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811752-1.00002-x · Cited by 1
HSF1 Regulates Cellular Senescence: Role of the DHRS2-MDM2-p53 Pathway
Yamashita, T. (2020) · Heat shock proteins · doi:10.1007/7515_2020_17 · Cited by 1
Autophagy in the cardiovascular system
Peña‐Oyarzún, D., Garrido‐Moreno, V., Garrido‐Olivares, L., Corbalan, R. L., Criollo, A., & Lavandero, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822003-0.00003-6 · Cited by 1
Aging, mitochondrial dysfunctions, and vitamin E
Napolitano, G., Fasciolo, G., & Venditti, P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90256-4.00025-4 · Cited by 1
Lautrup, S., Anisimov, A. S., Lagartos-Donate, M. J., & Fang, E. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91617-2.00010-9 · Cited by 4
Analysis of MTORC2 in regulating aging, metabolism and cardiac disease in Drosophila melanogaster
Chang, K. (2020) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-20210114-24 · Cited by 1
Chen, Y. (2019) · Louisiana State University · doi:10.31390/gradschool_dissertations.4974 · Cited by 1
Lérida‐Viso, A. (2023) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/194709 · Cited by 1
A Critical Role of Nrf2 In Protecting Cardiomyocytes Against Oxidative Stress and Ischemic Injury
Strom, J. G. (2014) · UA Campus Repository (The University of Arizona) · Cited by 4
Ma, L. (2017) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789813148574_0015
Johnston, A. (2017) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6065
Human induced pluripotent stem cell models used in the study of doxorubicin-induced cardiomyopathy
Maus, A. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8029
Aging, mitochondria, and autophagy
Wu, L., Zhang, Y., & Ren, J. T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85666-9.00005-x
Mitochondrial Dysfunction and Mitophagy: Physiological Implications in Cardiovascular Health
Gustafsson, Å. B. (2021) · Advances in biochemistry in health and disease · doi:10.1007/978-3-030-78799-8_11
Role of mitophagy in muscle growth and metabolism
Peker, N. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/72691
Espina, Á. G. (2022) · Preprints.org · doi:10.20944/preprints202202.0013.v1
“Furthermore, p53 is abnormally elevated and active in the CNS of patients with ALS, and it is a central regulator that drives neurodegeneration caused by intragenic repeat variants of C9orf72, key in familial and sporadic ALS [30, 31, 32, 33, 34, 39, 40].”
BackgroundKartha, C. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-85536-9_12
Wang, X., Ling, G., WeiLi, L. I., Wei, W. A. N. G., & Wang, Y. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0406
Diehl, J. A. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.725967101.793538077
Erratum to: The 2014 Beatson international cancer conference: powering the cancer machine
Kamphorst, J. J., & Murphy, D. J. (2014) · Cancer & Metabolism · doi:10.1186/s40170-014-0127-8
CARDIOLOGIA EM FOCO: PREVENÇÃO, DIAGNÓSTICO E TRATAMENTOS ATUAIS
Almeida, A. B., & Horevicht, C. M. (2023) · EPITAYA eBooks · doi:10.47879/ed.ep.2023809
Metadata
- Authors
- Hoshino, A., Mita, Y., Okawa, Y., Ariyoshi, M., Iwai-Kanai, E., Ueyama, T., Ikeda, K., Ogata, T., & Matoba, S.
- Affiliations
- Kyoto Prefectural University (JP)
- Corresponding author
- Matoba, Satoaki
- Venue
- Nature Communications
- Published
- 2013-08-06
- Volume
- 4
- Issue
- 1
- Pages
- 2308-2308
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2030548258
- Cited by
- 536
- References
- 54
- Citations by year
- 2026: 22 · 2025: 30 · 2024: 53 · 2023: 48 · 2022: 68 · 2021: 50 · 2020: 58 · 2019: 42 · 2018: 36 · 2017: 52 · 2016: 23 · 2015: 29 · 2014: 22 · 2013: 1
- FWCI
- 18.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Communications (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Parkin, mitophagy, mitochondrial dysfunction, heart failure, cardiac aging, mitochondrial quality control, autophagy, cellular senescence, doxorubicin cardiotoxicity, cardiac dysfunction
- MeSH terms
- Aging, Animals, Cytosol, Doxorubicin, Embryo, Mammalian, Fibroblasts, Heterozygote, Humans, Mice, Transgenic, Mitochondria, Myocardium, Protein Binding, Tumor Suppressor Protein p53, Cellular Senescence, Protein Structure, Tertiary, Protein Transport, Ubiquitin-Protein Ligases, HCT116 Cells, Mice, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.